Acceder

Análisis técnico y gráfico histórico de Ligand Pharmaceuticals Incorporated

Análisis fundamental y estadísticas clave de Ligand Pharmaceuticals Incorporated

Ficha de Ligand Pharmaceuticals Incorporated (LGND)

Ticker LGND
ISIN US53220K5048
Sector Atención sanitaria
Mercado NASDAQ

Análisis financiero de Ligand Pharmaceuticals Incorporated

Briefing Valoración Rentabilidad Métricas por acción Deuda Liquidez

Resumen financiero e información corporativa de Ligand Pharmaceuticals Incorporated

Invertir en Ligand Pharmaceuticals Incorporated en 2026: Preguntas frecuentes

¿Qué es Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae; and Pneumosil...

¿En qué sector opera Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated opera en el sector Healthcare, industria Biotechnology.

¿Cómo invertir en acciones?

Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.

Compara brokers para acciones